- Secondary trial endpoint reinforces prior, positive, sustained efficacy data -
08:50AM 12/09/09
Alert! Alert! Google Says DNS Is Important: Validates 10+ Years Of DNS Services Offered By Dyn Inc.
02:30PM 12/04/09
Watson Challenges Takeda's Rozerem Patent
Watson Pharmaceuticals challenges patent Takeda Pharmaceuticals' patent on Rozerem
09:24AM 12/04/09
Watson Files FDA Application For Generic Rozerem(R)
- Paragraph IV Litigation Underway -
08:30AM 12/04/09
Impax Buys Applications For 2 Watson Generics
Impax Labs buys rights to applications for generic version of Dronabinol and Dostinex
05:14PM 12/02/09
Watson 3Q Profit Falls 11 Percent On Taxes, Costs
Watson Pharmaceuticals' 3rd-quarter profit falls 11 percent on higher taxes, charges
09:50AM 11/04/09
Busy Global Economic Calendar Looms
Although Monday is a bank holiday in several countries, the rest of the week is jam-packed with important economic releases.
05:59PM 10/11/09
A Look At Economic Developments Around The Globe
A look at economic developments and activity in major stock markets around the world
02:14PM 09/24/09
'Fast Money' Recap: Surviving September
The trading panel discussed trading strategies for what is expected to a slow month.
07:43PM 08/31/09
Watson Gets Approval For Emergency Contraceptive
Watson Pharmaceuticals gets FDA approval for over-the-counter emergency contraceptive
05:23PM 08/28/09
CIT Future Looks Bright, for Bondholders
CIT Group bondholders are likely to make a lot of money, regardless of which avenue the troubled company pursues to revamp its funding model.
01:36PM 08/20/09



Connect with TheStreet